CVS provides FY14 outlook, lifts dividend, announces $6B repurchase authorization

|About: CVS Health Corporation (CVS)|By:, SA News Editor

CVS provides FY14 guidance at its analyst day.

FY14 outlook: Adjusted EPS of $4.36-4.50 (+10.25-13.75% Y/Y); GAAP diluted EPS of $4.09-4.23; FCF of $5.1-5.4B; completion of $4B in buybacks.

Quarterly dividend hiked by 22% to $0.275.

Board authorizes up to $6B in new buybacks. (PR)